**Core Concept**
Theophylline is a methylxanthine drug used in the management of COPD. It exerts its effects by inhibiting phosphodiesterases (PDEs), particularly PDE3 and PDE4. Inhibition of PDE4 is associated with various side effects due to its role in modulating inflammatory responses and immune cell function.

**Why the Correct Answer is Right**
The correct answer is related to the inhibition of PDE4, which is involved in the regulation of inflammatory cytokines and immune cell activation. Theophylline's inhibition of PDE4 leads to an increase in cyclic AMP (cAMP) levels, resulting in the suppression of inflammatory responses. However, this also leads to the enhancement of gastrointestinal side effects such as nausea, vomiting, and abdominal cramps. This is because PDE4 inhibition increases the release of histamine and other mediators in the gut, leading to increased gut motility and secretion.

**Why Each Wrong Option is Incorrect**
* **Option A:** Although theophylline can cause cardiac arrhythmias, this is not directly related to the inhibition of PDE4. Cardiac arrhythmias are more commonly associated with the inhibition of PDE3.
* **Option B:** Theophylline's inhibition of PDE4 does not directly lead to hepatotoxicity. Hepatotoxicity is a rare but serious side effect of theophylline, and its exact mechanism is not well understood.
* **Option C:** Theophylline's inhibition of PDE4 does not directly lead to hypophosphatemia. Hypophosphatemia is a rare side effect of theophylline, and its exact mechanism is not well understood.

**Clinical Pearl / High-Yield Fact**
Theophylline's side effect profile is complex and influenced by various factors, including its plasma levels, PDE3 and PDE4 inhibition, and individual patient factors. Clinicians should be aware of the potential for gastrointestinal side effects, particularly at higher doses or in patients with pre-existing gastrointestinal disorders.

**Correct Answer: C.**